{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:35:34Z","timestamp":1787668534135,"version":"build-2736575974"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES018884"],"award-info":[{"award-number":["ES018884"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM082978"],"award-info":[{"award-number":["GM082978"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES006694"],"award-info":[{"award-number":["ES006694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES020867"],"award-info":[{"award-number":["ES020867"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA023074"],"award-info":[{"award-number":["CA023074"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA092596"],"award-info":[{"award-number":["CA092596"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The effect of variations in the expression of cytochrome P450 reductase (CPR or POR) is determined in mice with decreased POR expression to identify potential vulnerabilities in people with low POR expression. There is an age-dependent appearance of increasing vacuolization in the proximal tubules of the renal cortex in 4- to 9-month-old male (but not female) Cpr-low (CL) mice. These mice have low POR expression in all cells of the body and upregulation of lysosome-associated membrane protein 1 expression in the renal cortex. Vacuolization is also seen in extrahepatic CL and extrarenal CL male mice, but not in mice with tissue-specific Por deletion in liver, intestinal epithelium, or kidney. The occurrence of vacuolization is accompanied by increases in serum blood-urea-nitrogen levels. Male CL mice are hypersensitive to cisplatin- and gentamicin-induced renal toxicity at 3 months of age, before proximal tubular (PT) vacuoles are detectable. At doses that do not cause renal toxicity in wild-type mice, both drugs cause substantial increases in serum blood-urea-nitrogen levels and PT vacuolization in male but not female CL mice. The hypersensitivity to drug-induced renal toxicity is accompanied by increases in circulating drug levels. These novel findings demonstrate deficiency of renal function in mice with globally reduced POR expression and suggest that low POR expression may be a risk factor for drug-induced nephrotoxicity in humans.<\/jats:p>","DOI":"10.1093\/toxsci\/kfz225","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T21:24:12Z","timestamp":1572557052000},"page":"362-372","source":"Crossref","is-referenced-by-count":18,"title":["Proximal Tubular Vacuolization and Hypersensitivity to Drug-Induced Nephrotoxicity in Male Mice With Decreased Expression of the NADPH-Cytochrome P450 Reductase"],"prefix":"10.1093","volume":"173","author":[{"given":"Liang","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona"},{"name":"College of Nanoscale Science and Engineering, SUNY Polytechnic Institute, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Wadsworth Center, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senyan","family":"Liu","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Wadsworth Center, Albany, New York"},{"name":"Kidney Institute & Division of Nephrology, Changzheng Hospital, Shanghai 200003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Bao","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Wadsworth Center, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen G","family":"Dickman","sequence":"additional","affiliation":[{"name":"Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York 11794"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart S","family":"Sell","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Wadsworth Center, Albany, New York"},{"name":"School of Public Health, State University of New York at Albany, Albany, New York 12201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Mei","sequence":"additional","affiliation":[{"name":"Kidney Institute & Division of Nephrology, Changzheng Hospital, Shanghai 200003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona"},{"name":"New York State Department of Health, Wadsworth Center, Albany, New York"},{"name":"School of Public Health, State University of New York at Albany, Albany, New York 12201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gu","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Wadsworth Center, Albany, New York"},{"name":"School of Public Health, State University of New York at Albany, Albany, New York 12201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona"},{"name":"College of Nanoscale Science and Engineering, SUNY Polytechnic Institute, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"2021032713273829100_kfz225-B1","doi-asserted-by":"crossref","first-page":"5551.","DOI":"10.1038\/srep05551","article-title":"Mice deficient in intestinal epithelium cytochrome P450 reductase are prone to acute toxin-induced mucosal damage","volume":"4","author":"Ahlawat","year":"2014","journal-title":"Sci. Rep"},{"key":"2021032713273829100_kfz225-B2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00007890-199402000-00001","article-title":"Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model","volume":"57","author":"Andoh","year":"1994","journal-title":"Transplantation"},{"key":"2021032713273829100_kfz225-B3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1081\/DMR-100101947","article-title":"Oxidant mechanisms in toxic acute renal failure","volume":"31","author":"Baliga","year":"1999","journal-title":"Drug Metab. Rev"},{"key":"2021032713273829100_kfz225-B4","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1046\/j.1523-1755.1998.00161.x","article-title":"Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity","volume":"54","author":"Baliga","year":"1998","journal-title":"Kidney Int"},{"key":"2021032713273829100_kfz225-B5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/infdis\/167.1.173","article-title":"Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring","volume":"167","author":"Bertino","year":"1993","journal-title":"J. Infect. Dis"},{"key":"2021032713273829100_kfz225-B6","doi-asserted-by":"crossref","first-page":"e0142225.","DOI":"10.1371\/journal.pone.0142225","article-title":"Understanding the risk factors and long-term consequences of cisplatin-associated acute kidney injury: An observational cohort study","volume":"10","author":"Bhat","year":"2015","journal-title":"PLoS One"},{"key":"2021032713273829100_kfz225-B7","first-page":"35","article-title":"P-450 cytochromes: Structure and function","volume":"60","author":"Black","year":"1987","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol"},{"key":"2021032713273829100_kfz225-B8","first-page":"F1181","article-title":"Mitochondrial injury: An early event in cisplatin toxicity to renal proximal tubules","volume":"258","author":"Brady","year":"1990","journal-title":"Am. J. Physiol"},{"key":"2021032713273829100_kfz225-B9","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.7150\/jca.20083","article-title":"Cisplatin nephrotoxicity might have a sex difference. An analysis based on women's sex hormone changes","volume":"8","author":"Chen","year":"2017","journal-title":"J. Cancer"},{"key":"2021032713273829100_kfz225-B10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ki.1979.132","article-title":"Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule","volume":"16","author":"Christensen","year":"1979","journal-title":"Kidney Int"},{"key":"2021032713273829100_kfz225-B11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ki.2013.462","article-title":"Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury","volume":"85","author":"Decleves","year":"2014","journal-title":"Kidney Int"},{"key":"2021032713273829100_kfz225-B12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6600884","article-title":"Weekly high-dose cisplatin is a feasible treatment option: Analysis on prognostic factors for toxicity in 400 patients","volume":"88","author":"de Jongh","year":"2003","journal-title":"Br. J. Cancer"},{"key":"2021032713273829100_kfz225-B13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.ajkd.2007.10.044","article-title":"Osmotic nephrosis: Acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes","volume":"51","author":"Dickenmann","year":"2008","journal-title":"Am. J. Kidney Dis"},{"key":"2021032713273829100_kfz225-B14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: An update","volume":"86","author":"dos Santos","year":"2012","journal-title":"Arch. Toxicol"},{"key":"2021032713273829100_kfz225-B15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000321221","article-title":"Clinical and biochemical consequences of p450 oxidoreductase deficiency","volume":"20","author":"Fluck","year":"2011","journal-title":"Endocr. Dev"},{"key":"2021032713273829100_kfz225-B16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/ped.12518","article-title":"Cytochrome P450 oxidoreductase deficiency: Rare congenital disorder leading to skeletal malformations and steroidogenic defects","volume":"56","author":"Fukami","year":"2014","journal-title":"Pediatr. Int"},{"key":"2021032713273829100_kfz225-B17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/pgs.09.7","article-title":"Pharmacogenomics of human liver cytochrome P450 oxidoreductase: Multifactorial analysis and impact on microsomal drug oxidation","volume":"10","author":"Gomes","year":"2009","journal-title":"Pharmacogenomics"},{"key":"2021032713273829100_kfz225-B18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/FPC.0000000000000297","article-title":"Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy","volume":"27","author":"Gong","year":"2017","journal-title":"Pharmacogenet. Genomics"},{"key":"2021032713273829100_kfz225-B19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.106.118240","article-title":"A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: Characterization and utility for in vivo studies of cyclophosphamide disposition","volume":"321","author":"Gu","year":"2007","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2021032713273829100_kfz225-B20","doi-asserted-by":"crossref","first-page":"25895","DOI":"10.1074\/jbc.M303125200","article-title":"Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: Impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase","volume":"278","author":"Gu","year":"2003","journal-title":"J. Biol. Chem"},{"key":"2021032713273829100_kfz225-B21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2008","journal-title":"Chem. Res. Toxicol"},{"key":"2021032713273829100_kfz225-B22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ki.2008.200","article-title":"Gender differences in predictors of the decline of renal function in the general population","volume":"74","author":"Halbesma","year":"2008","journal-title":"Kidney Int"},{"key":"2021032713273829100_kfz225-B23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FPC.0b013e3282f2f121","article-title":"Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism","volume":"18","author":"Hart","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"2021032713273829100_kfz225-B24","doi-asserted-by":"crossref","first-page":"13480","DOI":"10.1074\/jbc.M212087200","article-title":"Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase","volume":"278","author":"Henderson","year":"2003","journal-title":"J. Biol. Chem"},{"key":"2021032713273829100_kfz225-B25","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0006-2952(90)90077-X","article-title":"Formation of a cytotoxic metabolite from gentamicin by liver","volume":"40","author":"Huang","year":"1990","journal-title":"Biochem. Pharmacol"},{"key":"2021032713273829100_kfz225-B26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ki.2008.261","article-title":"Gender differences in chronic kidney disease","volume":"74","author":"Iseki","year":"2008","journal-title":"Kidney Int"},{"key":"2021032713273829100_kfz225-B27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11010-005-9110-6","article-title":"Erdosteine against acetaminophen induced renal toxicity","volume":"287","author":"Isik","year":"2006","journal-title":"Mol. Cell. Biochem"},{"key":"2021032713273829100_kfz225-B28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2215\/CJN.01320406","article-title":"A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies","volume":"2","author":"Kambham","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"2021032713273829100_kfz225-B29","first-page":"470","article-title":"Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin","volume":"12","author":"Kaminsky","year":"1984","journal-title":"Drug Metab. Dispos"},{"key":"2021032713273829100_kfz225-B30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.08070715","article-title":"Long-term renal outcomes after cisplatin treatment","volume":"11","author":"Latcha","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"2021032713273829100_kfz225-B31","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1046\/j.1523-1755.2003.00908.x","article-title":"Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis","volume":"63","author":"Liu","year":"2003","journal-title":"Kidney Int"},{"key":"2021032713273829100_kfz225-B32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.taap.2013.05.022","article-title":"The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: Utility of renal specific P450 reductase knockout mouse models","volume":"272","author":"Liu","year":"2013","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"2021032713273829100_kfz225-B33","first-page":"421","article-title":"Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran","volume":"11","author":"Maunsbach","year":"1962","journal-title":"Lab. Invest"},{"key":"2021032713273829100_kfz225-B34","doi-asserted-by":"crossref","first-page":"pt11.","DOI":"10.1126\/scisignal.2003318","article-title":"P450 oxidoreductase deficiency: A disorder of steroidogenesis with multiple clinical manifestations","volume":"5","author":"Miller","year":"2012","journal-title":"Sci. Signal"},{"key":"2021032713273829100_kfz225-B35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mce.2010.10.022","article-title":"Consequences of POR mutations and polymorphisms","volume":"336","author":"Miller","year":"2011","journal-title":"Mol. Cell. Endocrinol"},{"key":"2021032713273829100_kfz225-B36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-100-3-352","article-title":"Risk factors for nephrotoxicity in patients treated with aminoglycosides","volume":"100","author":"Moore","year":"1984","journal-title":"Ann. Intern. Med"},{"key":"2021032713273829100_kfz225-B37","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1128\/MCB.25.17.7770-7779.2005","article-title":"Disruption of aquaporin-11 produces polycystic kidneys following vacuolization of the proximal tubule","volume":"25","author":"Morishita","year":"2005","journal-title":"Mol. Cell. Biol"},{"key":"2021032713273829100_kfz225-B38","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/01926230701481956","article-title":"An immunohistochemical approach to differentiate hepatic lipidosis from hepatic phospholipidosis in rats","volume":"35","author":"Obert","year":"2007","journal-title":"Toxicol. Pathol"},{"key":"2021032713273829100_kfz225-B39","doi-asserted-by":"crossref","first-page":"e75638.","DOI":"10.1371\/journal.pone.0075638","article-title":"Conditional deletion of cytochrome p450 reductase in osteoprogenitor cells affects long bone and skull development in mice recapitulating Antley-Bixler syndrome: Role of a redox enzyme in development","volume":"8","author":"Panda","year":"2013","journal-title":"PLoS One"},{"key":"2021032713273829100_kfz225-B40","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1016\/S0021-9258(18)92717-1","article-title":"Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms","volume":"266","author":"Porter","year":"1991","journal-title":"J. Biol. Chem"},{"key":"2021032713273829100_kfz225-B41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00280-017-3358-x","article-title":"Involvement of cytochrome P450 in cisplatin treatment: Implications for toxicity","volume":"80","author":"Quintanilha","year":"2017","journal-title":"Cancer Chemother. Pharmacol"},{"key":"2021032713273829100_kfz225-B42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/dmd.112.048991","article-title":"NADPH-cytochrome P450 oxidoreductase: Roles in physiology, pharmacology, and toxicology","volume":"41","author":"Riddick","year":"2013","journal-title":"Drug Metab. Dispos"},{"key":"2021032713273829100_kfz225-B43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0003-9861(92)90152-M","article-title":"Quantification of cytochrome P450 reductase gene expression in human tissues","volume":"294","author":"Shephard","year":"1992","journal-title":"Arch. Biochem. Biophys"},{"key":"2021032713273829100_kfz225-B44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1734-1140(12)70728-4","article-title":"Animal models of acute renal failure","volume":"64","author":"Singh","year":"2012","journal-title":"Pharmacol. Rep"},{"key":"2021032713273829100_kfz225-B45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0076-6879(06)19009-6","article-title":"Kidney epithelial cells","volume":"419","author":"Smith","year":"2006","journal-title":"Methods Enzymol"},{"key":"2021032713273829100_kfz225-B46","first-page":"925","article-title":"Histological changes of liver glycogen storage in mice (Mus musculus) caused by high-protein diets","volume":"21","author":"Ulusoy","year":"2006","journal-title":"Histol. Histopathol"},{"key":"2021032713273829100_kfz225-B47","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1681\/ASN.V861028","article-title":"Mannitol-induced acute renal failure","volume":"8","author":"Visweswaran","year":"1997","journal-title":"J. Am. Soc. Nephrol"},{"key":"2021032713273829100_kfz225-B48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/jpet.110.167411","article-title":"Generation of a mouse model with a reversible hypomorphic cytochrome P450 reductase gene: Utility for tissue-specific rescue of the reductase expression, and insights from a resultant mouse model with global suppression of P450 reductase expression in extrahepatic tissues","volume":"334","author":"Wei","year":"2010","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2021032713273829100_kfz225-B49","doi-asserted-by":"crossref","first-page":"31686","DOI":"10.1074\/jbc.M504447200","article-title":"Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype","volume":"280","author":"Weng","year":"2005","journal-title":"J. Biol. Chem"},{"key":"2021032713273829100_kfz225-B50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ab.2010.03.034","article-title":"Analysis of testosterone and dihydrotestosterone in mouse tissues by liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"402","author":"Weng","year":"2010","journal-title":"Anal. Biochem"},{"key":"2021032713273829100_kfz225-B51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.104.073353","article-title":"Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: Effects on development, reproduction, and microsomal cytochrome P450","volume":"312","author":"Wu","year":"2005","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2021032713273829100_kfz225-B52","first-page":"83","article-title":"Human NADPH-P450 oxidoreductase: Complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7","volume":"36","author":"Yamano","year":"1989","journal-title":"Mol. Pharmacol"},{"key":"2021032713273829100_kfz225-B53","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1124\/dmd.108.025429","article-title":"An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: Direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine","volume":"37","author":"Zhang","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"2021032713273829100_kfz225-B54","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1124\/dmd.107.016543","article-title":"Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine","volume":"35","author":"Zhang","year":"2007","journal-title":"Drug Metab. Dispos"},{"key":"2021032713273829100_kfz225-B55","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1124\/dmd.111.038836","article-title":"Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose","volume":"39","author":"Zhang","year":"2011","journal-title":"Drug Metab. Dispos"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfz225\/30438564\/kfz225.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/173\/2\/362\/36759657\/kfz225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/173\/2\/362\/36759657\/kfz225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T05:05:36Z","timestamp":1664773536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/173\/2\/362\/5613849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,11,6]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfz225","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2019,11,6]]}}}